Shares of Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) opened at $0.336, and ended -0.9% lower at $0.33. Nearly 1.58 million shares were traded by the close, lower than its average daily volume of 1.85 million shares.Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) Intraday View
This stock (NWBO) is ahead of its 52-week low with 112.26%. Its last month’s stock price volatility remained 8.66% which for the week stands at 9.77%. The share price has moved forward from its 20 days moving average, trading at a distance of 27.52% and stays 40.25% away from its 50 days moving average. Over the last five days, shares have managed 18.56% gains and now is up 62.1% since hitting its 200-day moving average of $0.207. Northwest Biotherapeutics, Inc. (NWBO) has made its way to a 12-month decline of 0%.
Turning to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), its shares were trading at $4.16 a gain of $0.04, on the trading floor. The stock, after opening at $4.13, touched a high of $4.215 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.8. Rigel Pharmaceuticals, Inc. has 1 buy ratings, 0 holds and 0 sells even after the stock tumbled -7.04% from its high of $4.47 to a $637.15 million market value through last close.
The company’s consensus rating on Reuter’s scale improved from 1.75 to 1.83 during a month. Analysts set a 12-month price target of $5.83 a share. The target implies a 40.14% spike from where the shares are currently trading. Also, the current price highlights a discount of 68.27% to analysts’ high consensus price target.Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Intraday Trading
The counter witnessed a trading volume of 0.91 million shares versus an average volume of 1.43 million shares during last trading session. Its last month’s stock price volatility remained 5.33% which for the week approaches 5.35%. The lowest price the stock reached in the last trading day was $4.03 and compares with the $1.94 52-week low. The stock recovered 114.43% since its low point and has performed 7.22% year-to-date.